Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Despite MTX Therapy (P08683, MK-8457-008)
Clinical trial NCT01569152 · TERMINATED
Trial details
- NCT number
- NCT01569152
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-22
- Primary completion
- 2013-10-03
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.